Barchart Demo Center

Overview

Stocks

Stock Screeners

ETFs

Futures

Funds

Fund Screeners

Foreign Exchange

Sectors

News

Financial Calculators

Embedded Widgets

Portfolio

Screener

JSON Feeds

Symbol Overview

United States|Canada
English|French

Intellia Thera CS

(NASDAQ: NTLA)
Add to Portfolio
-0.69 (-4.90%)
as of Feb 21, 2020

Last 13.39
Change -0.69 (-4.90%)
Open 14.04
Prev. Close 14.08
Today's Range
13.24
14.14
52wk Range
10.26
19.00
Volume 580,608
Avg Volume 643,195
Sector SIC-2835 In Vitro & In Vivo Diagnostic Substances

Perfomance Comparison

Name Today 3-Month 1-Year
NTLA -4.90% -19.92% +2.84%
DJIA -0.78% +3.88% +12.15%
S&P 500 -1.05% +6.43% +20.28%

Key Statistics

Annual EPS -1.97
Dividend Yield 0.00%
P/E Ratio N/A
Market Capitalization, $K 684,840
Weighted Alpha -13.00
Standard Deviation -0.97
Profit Margin N/A
Beta 2.82

Growth Rates

YTD -8.73%
1-Year +3.99%
3-Year +14.94%

Opinion

Sell Hold Buy

Recent Headlines

Intellia (NTLA) to Report Q4 Earnings: What's in

ZACKS - Thu Feb 20, 10:53AM EST
Intellia (NTLA) is likely to provide an update on the IND application for its lead candidate NTLA-2001, currently being developed to address transthyretin amyloidosis.(full story)
NVS: 96.76 (+0.47), SAGE: 69.53 (-0.85), CLVS: 11.00 (+0.23), NTLA: 13.39 (-0.69)

Back from the Weekend and Back to New Highs

ZACKS - Tue Feb 11, 01:15AM EST
Back from the Weekend and Back to New Highs(full story)
SAVE: 41.10 (-0.15), DKS: 42.36 (-1.07), BBY: 90.26 (-1.67), ADNT: 26.97 (-1.27), AL: 43.33 (-1.33), MTW: 13.10 (+0.27), CAE: 30.20 (-0.19)

Implied Volatility Surging for Intellia (NTLA) Stock

ZACKS - Fri Feb 07, 08:54AM EST
Investors need to pay close attention to Intellia (NTLA) stock based on the movements in the options market lately.(full story)
NTLA: 13.39 (-0.69)

Has Intellia Therapeutics (NTLA) Outpaced Other

ZACKS - Wed Dec 25, 11:30AM EST
Is (NTLA) Outperforming Other Medical Stocks This Year?(full story)
NTLA: 13.39 (-0.69)

Gene Therapy the Next Best Thing: Here's Why (Revised)

ZACKS - Thu Dec 05, 03:49AM EST
Recent activities like mergers and collaboration have boosted the gene therapy space this year, the broad and intriguing pipelines shows that the segment is poised to grow.(full story)
NTLA: 13.39 (-0.69), VRTX: 246.29 (+1.19), QURE: 60.64 (-2.95), MGTX: 18.32 (+0.51), PIRS: 3.95 (+0.03)